Alexander Pasternak
Merck Research Laboratories
Rahway
NJ 07065
USA
Name/email consistency: high
- Discovery and optimization of novel 4-[(aminocarbonyl)amino]-N-[4-(2-aminoethyl)phenyl]benzenesulfonamide ghrelin receptor antagonists. Pasternak, A., Goble, S.D., deJesus, R.K., Hreniuk, D.L., Chung, C.C., Tota, M.R., Mazur, P., Feighner, S.D., Howard, A.D., Mills, S.G., Yang, L. Bioorg. Med. Chem. Lett. (2009)
- Potent heteroarylpiperidine and carboxyphenylpiperidine 1-alkyl-cyclopentane carboxamide CCR2 antagonists. Pasternak, A., Goble, S.D., Vicario, P.P., Di Salvo, J., Ayala, J.M., Struthers, M., DeMartino, J.A., Mills, S.G., Yang, L. Bioorg. Med. Chem. Lett. (2008)
- Novel, orally bioavailable gamma-aminoamide CC chemokine receptor 2 (CCR2) antagonists. Pasternak, A., Marino, D., Vicario, P.P., Ayala, J.M., Cascierri, M.A., Parsons, W., Mills, S.G., Maccoss, M., Yang, L. J. Med. Chem. (2006)